EGFR and prostate cancer: The enriched pathways in the low-risk group were clustered in apoptosis, prostate cancer, viral myocarditis, endocytosis, JAK-STAT signaling route, B cell receptor signaling pathway, and ERBB signaling pathway (Figure 8).